Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 1 Flow diagram of patient selection and study design.

Published byCora Barnett Modified over 6 years ago

Similar presentations

Presentation on theme: "Fig. 1 Flow diagram of patient selection and study design."— Presentation transcript:

1 Fig. 1 Flow diagram of patient selection and study design.
From: Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia Dis Esophagus. Published online September 27, doi: /dote/dox120 Dis Esophagus | © The Authors Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please

2 Fig. 2 Kaplan–Meier curves of progression to HGD/EAC by management strategy. P-value represents log-rank test for progression distribution between groups. From: Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia Dis Esophagus. Published online September 27, doi: /dote/dox120 Dis Esophagus | © The Authors Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please

Download ppt "Fig. 1 Flow diagram of patient selection and study design."

Similar presentations

Fig. 1. Flow diagram of study participants and outcomes.

Fig. 1. Flow diagram of study participants and outcomes.
From: An open day in the metric space

From: An open day in the metric space
Fig. 3. Plot of overall survival by adjuvant therapy for patient subgroups. (A) Patients with M0 disease (n = 411). (B) Patients receiving 36 Gy craniospinal.

Fig. 3. Plot of overall survival by adjuvant therapy for patient subgroups. (A) Patients with M0 disease (n = 411). (B) Patients receiving 36 Gy craniospinal.
Fig. 1 Flow chart of the COBRA-light trial and its extension study

Fig. 1 Flow chart of the COBRA-light trial and its extension study
Figure 1 The spatial and temporal distribution of diarrhoea rates

Figure 1 The spatial and temporal distribution of diarrhoea rates
Figure 1. Flow diagram of participants recruited into the study.

Figure 1. Flow diagram of participants recruited into the study.
Fig. 1 Graphical representation

Fig. 1 Graphical representation
Figure 1. FinHER dataset: distribution of tumor-infiltrating lymphocytes in breast cancer according to the (A) three breast cancer subtypes and (B) HER2.

Figure 1. FinHER dataset: distribution of tumor-infiltrating lymphocytes in breast cancer according to the (A) three breast cancer subtypes and (B) HER2.
Figure 2. CONSORT flow diagram.

Figure 2. CONSORT flow diagram.
Figure 1. Period–cohort diagram.

Figure 1. Period–cohort diagram.
Source:Rosnes and Vennemo 2009.

Source:Rosnes and Vennemo 2009.
From: Political Leadership and Power Redistribution

From: Political Leadership and Power Redistribution
Table 5 Village Characteristics Based on the Census of India 1991, by Mandate during which a First SHG was Created in the Village From: Public Good Provision.

Table 5 Village Characteristics Based on the Census of India 1991, by Mandate during which a First SHG was Created in the Village From: Public Good Provision.
Figure 1. Programme provisions, eligibility, evaluation period and geographical coverage of programme over time From: Impact evaluation of free delivery.

Figure 1. Programme provisions, eligibility, evaluation period and geographical coverage of programme over time From: Impact evaluation of free delivery.
Error bars represent the mean (s.e.).

Error bars represent the mean (s.e.).
Figure 1. Shiga toxin–producing Escherichia coli (STEC) isolates by method of initial detection and STEC serotype, Connecticut, 2000–2009. From: Ten-Year.

Figure 1. Shiga toxin–producing Escherichia coli (STEC) isolates by method of initial detection and STEC serotype, Connecticut, 2000–2009. From: Ten-Year.
pSS: primary SS; Scl: scleroderma.

pSS: primary SS; Scl: scleroderma.
Fig. 4 Disease gene prediction based on multiple CSNs

Fig. 4 Disease gene prediction based on multiple CSNs
Figure 3. Examples of tweets classified as ridicule.

Figure 3. Examples of tweets classified as ridicule.
Figure 1. Logos appearing in the choice experiment

Figure 1. Logos appearing in the choice experiment

Similar presentations

Ads by Google